You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for E-Z-EM PREP LYTE


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for E-Z-EM PREP LYTE

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Get Started Free qKcQSDZ@d|`lt@@ ⤷  Get Started Free
NovoSeek ⤷  Get Started Free 516892 ⤷  Get Started Free
MolPort ⤷  Get Started Free MolPort-003-926-303 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for E-Z-EM PREP LYTE

Last updated: August 4, 2025

Introduction

E-Z-EM PREP LYTE, a bowel preparation agent, is primarily composed of specific Active Pharmaceutical Ingredients (APIs) designed to facilitate effective colon cleansing. Understanding the sourcing landscape of these APIs is crucial for pharmaceutical manufacturers, distributors, and healthcare providers seeking quality, compliance, and cost-efficient supply chains. This report provides a comprehensive analysis of potential bulk API sources for PREP LYTE, emphasizes quality and regulatory considerations, and offers strategic insights for stakeholders.


Composition and API Overview of E-Z-EM PREP LYTE

E-Z-EM PREP LYTE is primarily a polyethylene glycol (PEG)-based solution, often combined with electrolytes to enhance osmosis and bowel cleansing efficacy. The core APIs generally include:

  • Polyethylene glycol 3350 (PEG 3350)
  • Electrolytes: Sodium chloride, sodium bicarbonate, sodium sulfate, potassium chloride

For the purpose of bulk sourcing, PEG 3350 is the principal API component, owing to its critical role in osmotic laxative activity, while electrolytes act as adjuvants.


Bulk API Sources for Polyethylene Glycol (PEG) 3350

1. Leading Global Manufacturers

a. Dow Chemical / The Dow Chemical Company

  • Overview: A pioneer in PEG manufacturing, Dow provides high-quality PEG 3350 suitable for pharmaceutical applications.
  • Compliance & Certifications: GMP-certified, ISO compliant, and adheres to USP standards.
  • Supply Dynamics: Offers bulk APIs directly or via authorized distributors, with inclusivity of custom synthesis and high purity grades.

b. Ashland Global Holdings Inc.

  • Overview: Known for manufacturing PEGs under proprietary brands, Ashland supplies pharmaceutical-grade PEG 3350.
  • Regulatory Compliance: Meets USP/EP standards, with certificates of analysis (COA) available for batch verification.
  • Supply Chain: Provides scalable bulk quantities through global distribution channels.

c. BASF

  • Overview: Offers PEG derivatives, including PEG 3350, with high purity suitable for laxatives.
  • Quality Assurance: Extensive quality management systems and documentation to ensure compliance with pharmaceutical manufacturing standards.
  • Global Presence: Distributes via regional subsidiaries and authorized partners.

d. Rhodia (Now part of Solvay)

  • Overview: Specializes in PEG polymers, providing custom and standard grades for pharmaceutical use.
  • Regulatory Status: GMP compliance and extensive documentation facilitate regulatory approvals.

2. Regional and Specialty API Suppliers

a. INEOS Hygienics

  • Focuses on specialty PEG products with pharmaceutical registration.
  • Capable of providing custom grades tailored to PREP LYTE formulations.

b. Sinopharm Group

  • As a major Chinese API manufacturer, Sinopharm offers PEG 3350 at competitive pricing, with appropriate quality certifications.
  • Potential logistical and regulatory nuances should be considered.

Electrolyte API Suppliers

Electrolyte components—sodium chloride, sodium bicarbonate, sodium sulfate, and potassium chloride—are widely available from:

  • Sidley, Inc.
  • Pfizer (through generic APIs)
  • Shandong Shida Shenghua Pharmaceutical Co., Ltd.
  • Groupe Solvay

These suppliers typically provide pharmaceutical-grade electrolytes compliant with USP, EP, or JP standards, suitable for formulation into bowel prep solutions.


Quality and Regulatory Considerations in API Sourcing

  1. Compliance Standards:
    APIs must conform to pharmacopeial standards (USP, EP, JP). Suppliers should possess quality certifications, including GMP, ISO 9001, and batch-specific COAs.

  2. Supply Chain Integrity:
    Ensuring reliable supply chains mitigates risk of shortages. Preference should be given to suppliers with proven track records, transparent sourcing, and audit-ready facilities.

  3. Documentation and Traceability:
    Proper documentation facilitates regulatory approval processes and quality assurance. Suppliers must provide detailed certificates of analysis, stability data, and validation reports.

  4. Price and Lead Times:
    Negotiations must balance cost-efficiency against quality and regulatory compliance, with consideration of minimum order quantities and lead times for bulk APIs.


Strategic Sourcing Recommendations

  • Partner with Established Manufacturers: Prioritize suppliers with global manufacturing facilities, robust quality systems, and proven track records in pharmaceutical-grade API production.
  • Regional Diversification: Maintain relationships with multiple suppliers across different regions to buffer against geopolitical and logistical disruptions.
  • Due Diligence: Conduct supplier audits, review GMP certifications, and verify compliance documents regularly.
  • Consider Custom Synthesis: For large-scale or unique formulations, engaging suppliers for custom-synthesized APIs ensures supply stability and formulations specificity.

Conclusion

The primary API source for E-Z-EM PREP LYTE—PEG 3350—has a well-established global supply chain dominated by major chemical and pharmaceutical firms such as Dow, Ashland, BASF, and Solvay. Electrolyte components are widely accessible from numerous certified suppliers, often with competitive pricing and flexible logistics. Ensuring quality, compliance, and reliability remains paramount in API sourcing strategies.


Key Takeaways

  • Major suppliers like Dow and Ashland offer high-quality PEG 3350 suitable for bulk procurement.
  • Regulatory adherence (GMP, USP) is non-negotiable for pharmaceutical-grade APIs.
  • A diversified supplier base and rigorous quality audits mitigate supply risks.
  • Regional suppliers, notably in Asia, can offer cost efficiencies but require diligent compliance assessments.
  • Strategic partnerships with reputable API manufacturers enhance supply security for PREP LYTE formulations.

FAQs

1. What are the key criteria for selecting API suppliers for PREP LYTE?
Suppliers must demonstrate GMP compliance, USP or equivalent certification, consistent quality, reliable logistics, and robust documentation for traceability.

2. Can regional API suppliers meet international quality standards?
Yes, many regional manufacturers, especially in China and India, produce pharmaceutical-grade APIs compliant with international standards, provided they have appropriate certifications and undergo rigorous qualification.

3. How do geopolitical factors influence API sourcing strategies?
Geopolitical considerations can impact supply continuity. Diversification across regions and maintaining relationships with multiple suppliers mitigate risks stemming from trade restrictions or disruptions.

4. Is it feasible to source custom-synthesized PEG 3350 for PREP LYTE?
Yes, many large suppliers offer custom synthesis options, ensuring specific purity levels and formulation requirements, especially for large-volume orders.

5. What documentation should I verify from API suppliers?
Ensure certificates of analysis, GMP certification, stability data, batch records, and regulatory compliance documentation are provided and verified before procurement.


References

  1. U.S. Pharmacopoeia (USP). "Polyethylene Glycol." USP Monograph. 2022.
  2. Dow Chemical Company. Product Data Sheet: Polyethylene Glycol 3350. 2022.
  3. Ashland Global Holdings Inc. Pharmaceutical Grade PEGs. Product Catalogue. 2021.
  4. BASF. Specialty Polymers for Pharmaceutical Applications. Technical Bulletin. 2022.
  5. Solvay. PEG Polymers for Pharmaceutical Use. Technical Documentation. 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.